Jonathan McNeill

VP, Business Development at Dyne Therapeutics

Jonathan brings life science business development and corporate strategy experience to Dyne. Most recently, Jonathan held a business development role at Editas Medicine, where he completed a variety of significant transactions, led strategic planning activities and collaborated on the company’s initial public offering. Prior to Editas, Jonathan was a consultant at the Boston Consulting Group, focusing on the pharmaceutical and biotechnology sectors. He was previously a healthcare services researcher at The University of North Carolina at Chapel Hill. Jonathan earned his M.D. from the Perelman School of Medicine at the University of Pennsylvania and his B.A. in public policy and economics from UNC Chapel Hill, where he was a Morehead-Cain Scholar.
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.